Anumana, a joint venture between EHR data company nference and the Mayo Clinic, announced last week it had entered a strategic partnership with pharma giant Novartis to develop artificial intelligence tools to detect cardiovascular diseases.
The collaboration will focus on deploying AI algorithms that analyze ECGs to find left ventricular dysfunction, which can lead to heart failure, and...
Digital chronic condition management company One Drop on Wednesday launched its newest product aimed at cardiovascular disease prevention.
The tool — the first to come out of a partnership between the digital health company and pharma giant Bayer — allows users to track blood pressure and weight in the app using connected devices, log meals, receive coaching from registered nurses, learn AI-...
Queensland-based digital health firm Cardihab and Baker Heart and Diabetes Institute, a medical research organisation in Melbourne, have signed a five-year agreement to jointly conduct clinical trials and cohort studies to deliver evidence of the effectiveness of digital approaches to cardiovascular disease management, rehabilitation, prevention and treatment.
The research programme will see wide...
Omron Healthcare and Kyoto University are set to undertake a study under a joint research programme to use artificial intelligence and home-recorded health data in predicting early signs of cardiovascular diseases.
WHY IT MATTERS
In a press statement, Omron said their upcoming study under the Healthcare Medical AI research programme will focus on two themes: First, the development of a novel...
Copenhagen and London-based healthtech company, Liva Healthcare has announced today that it is bringing its human coaching programmes to Germany to help manage conditions such as type 2 diabetes, obesity, and cardiovascular disease.
Germany will be Liva’s ninth market, with the company planning to open an office in Berlin. Liva is already operational in Britain, Australia, Ireland, Holland,...
The Korea Institute of Machinery and Materials, a research body under South Korea's Ministry of Science and ICT, said its researchers have developed a cardiovascular event prediction model that enhances the speed and accuracy of disease diagnosis.
Researchers led by Dr Jong-won Park, head of the institute's Department of Reliability Assessment, collaborated with the cardiology research group at...
As mobile health technology continues to become ubiquitous, it can be a helpful management tool for older adults with existing heart disease, according to the American Heart Association.
The AHA conducted a systematic review of studies of older adults who used mobile health technologies to manage their cardiovascular disease. It included 26 studies that examined mobile health technologies for...
iPhones and Apple Watches could enable at-home assessment of cardiovascular disease patients' frailty via sensor data and an app-guided version of the six-minute walk test (6MWT), a traditionally clinic-based assessment of a person's functional capacity, according to data published yesterday in PLoS One.
Conducted by Stanford University researchers and funded by Apple, the study provided 110...
German pharma giant Bayer and British biotech firm Exscientia have announced a three-year partnership focused on the use of Artificial Intelligence in cardiovascular and oncology drug discovery.
The collaboration will initially see the companies work on three early-stage research projects, combining Bayer’s data and drug discovery capabilities and Exscientia’s Centaur Chemist platform.
According...
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes.
So of course it’s little surprise that cardiovascular health and care...
